FEGOX
Price
$48.14
Change
-$0.24 (-0.50%)
Updated
Dec 3 closing price
Net Assets
5.13B
SGGDX
Price
$54.05
Change
-$0.67 (-1.22%)
Updated
Dec 2 closing price
Net Assets
5.22B
Interact to see
Advertisement

FEGOX vs SGGDX

Header iconFEGOX vs SGGDX Comparison
Open Charts FEGOX vs SGGDXBanner chart's image
First Eagle Gold C
Price$48.14
Change-$0.24 (-0.50%)
VolumeN/A
Net Assets5.13B
First Eagle Gold A
Price$54.05
Change-$0.67 (-1.22%)
VolumeN/A
Net Assets5.22B
FEGOX vs SGGDX Comparison Chart in %
View a ticker or compare two or three
VS
FEGOX vs. SGGDX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEGOX is a StrongBuy and SGGDX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SGGDX (5.22B) and FEGOX (5.13B) have equal amount of cash in the bank . SGGDX (2.44) and FEGOX (2.36) have matching dividends . FEGOX was incepted earlier than SGGDX: FEGOX (23 years) vs SGGDX (32 years). FEGOX (1.91) is less costly to investors than SGGDX (1.16). FEGOX (60.97) and SGGDX (60.97) have comparable annual turnover. FEGOX (2500) and SGGDX (2500) have matching initial minimum investment requirements. SGGDX (103.34) and FEGOX (101.81) have marching annual gain over last year. SGGDX return over 5 years is better than : 134.84 vs. FEGOX (126.36).
FEGOXSGGDXFEGOX / SGGDX
Total Expense Ratio1.911.16165%
Annual Report Gross Expense Ratio1.911.16165%
Fund Existence23 years32 years-
Gain YTD114.781116.28599%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets5.13B5.22B98%
Annual Yield % from dividends2.362.4497%
Returns for 1 year101.81103.3499%
Returns for 3 years147.69153.3196%
Returns for 5 years126.36134.8494%
Returns for 10 years351.98386.6491%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSJX26.83N/A
N/A
MFS Research International R4
AHSCX13.95N/A
N/A
Alger Health Sciences C
NGDRX33.61N/A
N/A
Neuberger Berman Large Cap Growth R3
HADRX85.15N/A
N/A
Horizon Defined Risk Advisor
GMAZX18.36N/A
N/A
GMO International Opportunistic Val IV